Beyond Borders: Boom, Boom, Biotech
The 34th edition of the Ernst & Young LLP (EY US) Beyond Borders report finds US and European biotech companies are seeing early signs of a thaw in the financing and dealmaking environment. Change in fiscal policy by lowering the interest rates in the months ahead can accelerate this positive shift within the second half…
